National Huntington's Disease Awareness Day

National Huntington's Disease Awareness Day hits every May 15th. The Huntington's Disease Society of America teams up with groups from Europe, Canada, Africa, and Asia for this coordinated push.

HD means genetic certainty, plain and simple. Every child of someone with HD faces 50-50 odds. Families end up watching multiple generations fight this brain condition that attacks movement, thinking, and emotions. Current data puts it at 40,000 Americans living with HD right now; another 200,000 carry the genetic risk. But the numbers don't tell the whole family story here.

Quick Links: National Huntington's Disease Awareness Day

The Important Need Behind This Global Observance

Half of at-risk people will develop Huntington's through autosomal dominant inheritance. Many avoid testing because of the psychological effect. Others don't even know their family history.

Symptoms typically start between ages 30-50, which creates dangerous delays in diagnosis. Research examining nearly 5,000 patients finds average delays of 3.78 years from symptom onset to diagnosis. More concerning? Black patients get diagnosed 4.6 years after symptoms appear compared to 3.7 years for White patients.

Dr. Nikolaus McFarland, who directs the UF Huntington's Disease Clinic, points out that "the future for HD patients appears brighter each year with the advances in our understanding of the disease." And yet family cascade results multiply when one diagnosis reveals multiple affected relatives.

Research funding shortfalls limit therapeutic progress. Neurological disease stigma persists too. This might explain why suicide rates in the HD community reach up to 10 times the national average. Through awareness days, we can break down misconceptions about symptoms and how the disease progresses.

Important HD Statistics and Global Effect

Global prevalence has jumped to 4.88 cases per 100,000 people. That's an 80% increase from earlier estimates of 2.71 per 100,000. This change reflects better genetic testing and less diagnostic stigma rather than actual disease increases.

North American populations show the highest documented rates: 8.87 cases per 100,000 people. European populations hit 6.37 cases per 100,000. Asian populations report much lower rates around 0.40 to 0.67 cases per 100,000.

Most symptoms emerge during peak career and family-building years between ages 30-50.

Evolution of HD Awareness Movement

• 1872:

  American physician George Huntington publishes “On Chorea,” describing the disease’s hereditary pattern and characteristic symptoms. The paper establishes the clinical description that later gives Huntington’s disease its name.

• 1967:

  Marjorie Guthrie and five volunteers establish the Committee to Combat Huntington’s Disease to support affected families and advance research. The organization is incorporated on September 18 and later becomes the Huntington’s Disease Society of America (HDSA).

• 1967:

  An international group of neurologists organizes a research group focused on Huntington’s chorea, helping strengthen scientific collaboration and interest in understanding the disease.

• 1983:

  Researchers identify the first genetic marker closely linked to Huntington’s disease, opening a path toward locating the responsible gene and improving risk prediction.

• 1987:

  Researchers narrow the location of the HD gene to the tip of chromosome 4, a major step toward identifying the genetic cause of the disease.

• 1992:

  U.S. President George H. W. Bush officially proclaims May as National Huntington’s Disease Awareness Month on May 18, helping establish May as a recurring period for public education and advocacy.

• 1993:

  The Huntington’s Disease Collaborative Research Group identifies the gene responsible for HD and reports the CAG repeat expansion in the HTT gene. The discovery enables direct genetic testing for the disease-causing mutation. The landmark paper is published on March 26.

• 2004:

  HDSA develops a drug-discovery pipeline connecting basic research, translational research, and clinical trials to accelerate the development of potential HD treatments.

• 2017:

  HDSA marks 50 years since the founding of the Committee to Combat Huntington’s Disease, recognizing five decades of advocacy, family support, and research efforts.

How to Meaningfully Participate and Advocate

Landmark Illumination Campaigns - Request blue and purple lighting for local monuments, bridges, and civic buildings throughout May. The Light It Up 4 HD campaign has successfully lit up 214 sites worldwide; that includes 56 locations across Canada alone.

Personal Story Amplification - Share authentic HD experiences using #LetsTalkAboutHD hashtags. Katie Jackson, CEO of Help4HD International, explains her motivation: "My husband passed away with no therapies, no treatments that worked for him... I am going to continue to fight so that does not happen to my children."

Strategic Research Fundraising - Organize community events that benefit clinical trial advancement. Direct donations speed up therapeutic development through organizations like HDSA Centers of Excellence.

Advocating for genetic counseling promotes accessible services within healthcare systems. Many at-risk individuals need professional guidance for family planning decisions, given the 50% inheritance probability.

Local support network development connects families with HDSA chapters providing ongoing support programs. Isolation makes HD's emotional devastation significantly worse.

Clinical trial participation promotion encourages enrollment in studies like ENROLL-HD, which includes over 20,000 participants across the globe, achieving an 80% survival probability at 7 years for premanifest participants.

Core Advocacy Messages That Drive Change

Consistent messaging themes create lasting results across diverse audiences. Genetic testing access remains most important—early detection through neurofilament light protein biomarkers enables better family planning and medical management years before symptoms start.

Clinical trials offer real therapeutic hope. Louise Vetter, who served 15 years as HDSA President and CEO, observed that "HD families are the strongest, most resilient group of people I've ever met in my life. They show such strength and grace that it's hard not to be inspired."

Beyond this, early intervention strategies improve quality of life during the 15-year presymptomatic period. Family support networks strengthen resilience when facing genetic certainty. Reducing neurological disease isolation benefits entire communities through open conversations that eliminate movement disorder stigma.

But what's the real timeline here? Research hope messaging balances realism with optimism; breakthrough therapies targeting CAG repeat mechanisms indicate unprecedented promise.

Sustaining Results Through Year-Round Engagement

Whether you choose May 15 or the whole month, your engagement is vital to community action, which you can do all year-round.

HDSA chapters provide monthly support meetings and educational programs. Clinical trial registries connect eligible participants with cutting-edge research opportunities. Genetic counseling resources guide families through complex inheritance decisions. Share these resources until they reach those who need them the most.

Help more people diagnosed with other brain disorders by joining National Alzheimer's Disease Awareness Month and World Parkinson's Day.

Resources:

FAQs (Frequently Asked Questions)